Niagen Bioscience, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Niagen Bioscience, Inc. reported Cash And Cash Equivalents At Carrying Value of $28.22 million for the year ending 2021.

  • Niagen Bioscience, Inc. showed an increase of +69.0% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 14, 2022.
  • XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2019 to 2021), Niagen Bioscience, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 50.0%.
  • Historical annual values: Fiscal year 2021: $28.22 million | Fiscal year 2020: $16.70 million | Fiscal year 2019: $18.81 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: